Modulate Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

Modulate Bio General Information

Description

Provider of allosteric small-molecule therapies intended to treat neurological disorders, namely essential tremor, epilepsy, and anxiety. The company is addressing on-target toxicology at the GABA-A receptor by developing controlled GABA-A positive allosteric modulators and leveraging a proprietary computational model and an advanced in vitro screening funnel, thereby enabling patients to receive an effective and safe therapy for essential tremor.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Pagliuca Harvard Life Lab
  • 127 Western Avenue
  • Allston, MA 02134
  • United States
+1 (603)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Pagliuca Harvard Life Lab
  • 127 Western Avenue
  • Allston, MA 02134
  • United States
+1 (603)

Modulate Bio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Modulate Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator Completed Pre-Clinical Trials
6. Seed Round 18-Jul-2025 Completed Pre-Clinical Trials
5. Accelerator/Incubator 10-Oct-2024 Completed Startup
4. Accelerator/Incubator 01-Oct-2024 Completed Startup
3. Grant 01-Jan-2024 Completed Startup
2. Accelerator/Incubator 11-Dec-2023 Completed Startup
1. Accelerator/Incubator 01-Jan-2023 Completed Startup
To view Modulate Bio’s complete valuation and funding history, request access »

Modulate Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Modulate Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bija Ventures Venture Capital Minority
Novaterra Holding Venture Capital Minority
Palo Santo Venture Capital Minority
Phoenix Investment Club (San Francisco) Venture Capital Minority
Pillar VC Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Modulate Bio FAQs

  • When was Modulate Bio founded?

    Modulate Bio was founded in 2023.

  • Where is Modulate Bio headquartered?

    Modulate Bio is headquartered in Allston, MA.

  • What is the size of Modulate Bio?

    Modulate Bio has 4 total employees.

  • What industry is Modulate Bio in?

    Modulate Bio’s primary industry is Drug Discovery.

  • Is Modulate Bio a private or public company?

    Modulate Bio is a Private company.

  • What is Modulate Bio’s current revenue?

    The current revenue for Modulate Bio is .

  • How much funding has Modulate Bio raised over time?

    Modulate Bio has raised $785K.

  • Who are Modulate Bio’s investors?

    Bija Ventures, Novaterra Holding, Palo Santo, Phoenix Investment Club (San Francisco), and Pillar VC are 5 of 11 investors who have invested in Modulate Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process